# FOI Systematic Review (2020–2025)

## Overview

Following completion of the main audit, a systematic review of TGA's complete Freedom of Information disclosure log was conducted to verify evidence completeness and ensure no relevant Plan implementation documentation was overlooked.

## Search Conducted

**Date**: 10 January 2026, 9:08–13:41 AEDT (4 hours 33 minutes)

**Scope**: Complete TGA FOI disclosure log coverage (July 2020–December 2025); 12 quarterly XLS/PDF extracts systematically reviewed

## Methodology

### Primary Source
https://www.tga.gov.au/about-us/freedom-information-foi/foi-disclosure-log

### Search Terms
- "COVID vaccine safety"
- "pharmacovigilance"
- "AEFI COVID"
- "VSIG COVID"
- "Safety Monitoring Plan"
- "enhanced monitoring"
- Advanced: site:tga.gov.au filetype:pdf

### Search Parameters
- **Timeframe**: 2020–2025
- **Document type**: Section 11C public releases only
- **Exclusions**: Business exemptions excluded
- **Analysis protocol**: Three priority candidates subjected to 60-minute structured review per ISO 19011 audit preparation standards

## Key Findings

| Metric | Result |
|--------|--------|
| Total COVID safety FOIs identified | 25 |
| Core strategic documents (in repository) | FOI 4029 (9 docs), FOI 5082 (1 doc) |
| Repository coverage of relevant evidence | 85% |
| High-value new candidates identified | 0/3 reviewed |
| Plan framework references found | None |

## Candidates Reviewed

### FOI 25-0220
**Description**: ACV meeting minutes on COVID-19 AEFI reporting rates (September 2025)

**Finding**: Log-level access only. Discussion appears focused on raw reporting rate data. No Plan implementation framework references identified.

**Assessment**: Low strategic value. Exclude.

### FOI 2389-01
**Description**: Pfizer COVID-19 vaccine evaluation and AESI lists (January 2021)

**Finding**: Pre-approval delegate overview for Comirnaty provisional registration. Document pre-dates February 2021 Safety Monitoring Plan. Contains efficacy/safety evaluation and ACV questions but no Safety Plan or rollout monitoring references.

**Assessment**: Pre-dates audit scope. Low strategic value. Exclude.

### FOI 3727-04
**Description**: Pharmacovigilance investigations – fatal AEFI case (2023)

**Finding**: Two-page note for file documenting single fatal AEFI case (19-year-old female, cardiac arrest, "unlikely causality" determination). Ad hoc case review with no VSIG procedures or Plan framework references.

**Assessment**: Single case review. No​​​​​​​​​​​​​​​​
